Nanoveu Limited
NNVUF
$0.07
-$0.004-5.41%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -93.50% | -61.62% | -34.48% | -37.10% | -38.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -93.50% | -61.62% | -34.48% | -37.10% | -38.90% |
| Cost of Revenue | -104.72% | -74.12% | -49.76% | -32.85% | -14.31% |
| Gross Profit | -58.68% | -16.46% | 30.67% | -45.32% | -67.51% |
| SG&A Expenses | 29.14% | 11.24% | -6.25% | -12.19% | -17.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.83% | 15.33% | 4.31% | -5.00% | -12.20% |
| Total Operating Expenses | 26.53% | 13.97% | 0.22% | -9.48% | -17.59% |
| Operating Income | -32.25% | -17.72% | -1.99% | 7.86% | 16.20% |
| Income Before Tax | -31.30% | -16.46% | -0.62% | 12.35% | 22.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.30% | -16.46% | -0.62% | 12.35% | 22.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.30% | -16.46% | -0.62% | 12.35% | 22.80% |
| EBIT | -32.25% | -17.72% | -1.99% | 7.86% | 16.20% |
| EBITDA | -42.37% | -25.81% | -3.24% | 11.04% | 22.83% |
| EPS Basic | -5.41% | 19.15% | 33.93% | 45.59% | 53.75% |
| Normalized Basic EPS | 0.00% | 20.00% | 33.33% | 44.19% | 52.00% |
| EPS Diluted | -5.41% | 19.15% | 33.93% | 45.59% | 53.75% |
| Normalized Diluted EPS | 0.00% | 20.00% | 33.33% | 44.19% | 52.00% |
| Average Basic Shares Outstanding | 26.20% | 33.41% | 42.56% | 51.48% | 62.95% |
| Average Diluted Shares Outstanding | 26.20% | 33.41% | 42.56% | 51.48% | 62.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |